Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12133986 | 0.87 | CA2 (0.51) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL18195526 | 0.83 | CA2 (0.48) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL18395904 | 0.82 | CA2 (0.56) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL6575404 | 0.82 | CA2 (0.56) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL461346 | 0.82 | CA2 (0.56) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL6943821 | 0.82 | CA2 (0.56) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL13063460 | 0.81 | CA2 (0.51) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL15225887 | 0.80 | CA2 (0.54) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL15226054 | 0.80 | CA2 (0.54) | CA2HTR7ALDH1A1NPSR1TMEM97 | |
| SCHEMBL18395905 | 0.80 | CA2 (0.54) | CA2HTR7ALDH1A1NPSR1TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227415-A1 | TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230227415-A1 | TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| EP-4169910-A1 | TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF | Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) | 2023-04-26 | — | — | EP | disclosed |
| WO-2021259224-A1 | TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF | 沈阳中化农药化工研发有限公司 | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227415-A1 | TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF | NOTUM, CYP3A5, DDT | CA2 381/4885HTR7 1955/4885ALDH1A1 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.